New foam treatment for kids with psoriasis shows promise in early study
NCT ID NCT07340216
First seen Jan 17, 2026 · Last updated May 23, 2026 · Updated 12 times
Summary
This study tested a medicated foam called ARQ-154 on 22 children aged 2 to 12 with scalp and body psoriasis. The goal was to see how much of the drug gets into the blood and if it is safe. Children applied the foam once daily for two weeks, and researchers checked for side effects and measured drug levels.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PSORIASIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Arcutis Clinical Study Site 104
Arlington, Texas, 76011, United States
-
Arcutis Clinical Study Site 105
West Lafayette, Indiana, 47906, United States
-
Arcutis Clinical Study Site 106
Bryant, Arkansas, 72022, United States
-
Arcutis Clinical Study Site 107
Miami Lakes, Florida, 33014, United States
-
Arcutis Clinical Study Site 108
Meridian, Idaho, 83646, United States
Conditions
Explore the condition pages connected to this study.